Biolase (FRA:BTH0) Short-Term Debt : €2.08 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Biolase Short-Term Debt?

Biolase's Short-Term Debt for the quarter that ended in Dec. 2023 was €2.08 Mil.

Biolase's quarterly Short-Term Debt increased from Jun. 2023 (€1.94 Mil) to Sep. 2023 (€2.62 Mil) but then declined from Sep. 2023 (€2.62 Mil) to Dec. 2023 (€2.08 Mil).

Biolase's annual Short-Term Debt increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.66 Mil) and increased from Dec. 2022 (€0.66 Mil) to Dec. 2023 (€2.08 Mil).

Biolase Short-Term Debt Historical Data

The historical data trend for Biolase's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolase Short-Term Debt Chart

Biolase Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

12.12

0.66

2.08

Biolase Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															0.66	1.31	1.94	2.62	2.08

Biolase Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biolase Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Biolase's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolase (FRA:BTH0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolase Inc (FRA:BTH0) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

BIOL:USA BTH0:Germany

Address

27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610

Website

https://www.biolase.com

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.

Biolase (FRA:BTH0) Headlines

No Headlines